The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Analytical strategies for identifying drug metabolites
Abstract
With the dramatic increase in the number of new chemical entities (NCEs) arising from combinatorial chemistry and modern high‐throughput bioassays, novel bioanalytical techniques are required for the rapid determination of the metabolic stability and metabolites of these NCEs. Knowledge of the metabolic site(s) of the NCEs in early drug discovery is essential for selecting compounds with favorable pharmacokinetic credentials and aiding medicinal chemists in modifying metabolic “soft spots”. In development, elucidation of biotransformation pathways of a drug candidate by identifying its circulatory and excretory metabolites is vitally important to understand its physiological effects. Mass spectrometry (MS) and nuclear magnetic resonance (NMR) have played an invaluable role in the structural characterization and quantification of drug metabolites. Indeed, liquid chromatography (LC) coupled with atmospheric pressure ionization (API) MS has now become the most powerful tool for the rapid detection, structure elucidation, and quantification of drug‐derived material within various biological fluids. Often, however, MS alone is insufficient to identify the exact position of oxidation, to differentiate isomers, or to provide the precise structure of unusual and/or unstable metabolites. In addition, an excess of endogenous material in biological samples often suppress the ionization of drug‐related material complicating metabolite identification by MS. In these cases, multiple analytical and wet chemistry techniques, such as LC‐NMR, enzymatic hydrolysis, chemical derivatization, and hydrogen/deuterium‐exchange (H/D‐exchange) combined with MS are used to characterize the novel and isomeric metabolites of drug candidates. This review describes sample preparation and introduction strategies to minimize ion suppression by biological matrices for metabolite identification studies, the application of various LC‐tandem MS (LC‐MS/MS) techniques for the rapid quantification and identification of drug metabolites, and future trends in this field. © 2007 Wiley Periodicals, Inc., Mass Spec Rev
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Electrospray ion source. Another variation on the free-jet theme
Yamashita, M., & Fenn, J. B. (1984) · The Journal of Physical Chemistry · doi:10.1021/j150664a002 · Cited by 2,082
The Orbitrap: a new mass spectrometer
Hu, Q., Noll, R. J., Li, H., Makarov, A., Hardman, M., & Graham Cooks, R. (2005) · Journal of Mass Spectrometry · doi:10.1002/jms.856 · Cited by 1,333
From ions in solution to ions in the gas phase - the mechanism of electrospray mass spectrometry
Kebarle, P., & Tang, L. (1993) · Analytical Chemistry · doi:10.1021/ac00070a001 · Cited by 781
Robb, D. B., Covey, T. R., & Bruins, A. P. (2000) · Analytical Chemistry · doi:10.1021/ac0001636 · Cited by 748
Metabolic profiles of cancer cells
Griffin, J. L., & Shockcor, J. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1390 · Cited by 725
An Introduction to Quadrupole Ion Trap Mass Spectrometry
March, R. E. (1997) · Journal of Mass Spectrometry · doi:10.1002/(sici)1096-9888(199704)32:4<351::aid-jms512>3.0.co;2-y · Cited by 708
Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., & Baillie, T. A. (2004) · Chemical Research in Toxicology · doi:10.1021/tx034170b · Cited by 706
A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups
Kalgutkar, A., Gardner, I., Obach, R., Shaffer, C., Callegari, E., Henne, K., Mutlib, A., Dalvie, D., Lee, J., Nakai, Y., et al. (2005) · Current Drug Metabolism · doi:10.2174/1389200054021799 · Cited by 616
Self-citationNegative ion production with the electrospray ion source
Yamashita, M., & Fenn, J. B. (1984) · The Journal of Physical Chemistry · doi:10.1021/j150664a046 · Cited by 581
Horning, E. C., Horning, M. G., Carroll, D. I., Dzidic, I., & Stillwell, R. N. (1973) · Analytical Chemistry · doi:10.1021/ac60328a035 · Cited by 552
Schmidt, A., Karas, M., & Dülcks, T. (2003) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(03)00128-4 · Cited by 534
MetaSite: Understanding Metabolism in Human Cytochromes from the Perspective of the Chemist
Cruciani, G., Carosati, E., De Boeck, B., Ethirajulu, K., Mackie, C., Howe, T., & Vianello, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050529c · Cited by 496
Lab-on-a-chip for drug development
Weigl, B. H., Bardell, R. L., & Cabrera, C. R. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00223-5 · Cited by 481
A new linear ion trap mass spectrometer
Hager, J. W. (2002) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.607 · Cited by 479
Liquid chromatography/mass spectrometry
Covey, T. R., Lee, E. D., Bruins, A. P., & Henion, J. D. (1986) · Analytical Chemistry · doi:10.1021/ac00127a001 · Cited by 469
Shevchenko, A., Chernushevich, I., Ens, W., Standing, K. G., Thomson, B., Wilm, M., & Mann, M. (1997) · Rapid Communications in Mass Spectrometry · doi:10.1002/(sici)1097-0231(19970615)11:9<1015::aid-rcm958>3.0.co;2-h · Cited by 454
HPLC-MS-based methods for the study of metabonomics
WILSON, I., PLUMB, R., GRANGER, J., MAJOR, H., WILLIAMS, R., & LENZ, E. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.07.045 · Cited by 447
Drug Metabolites in Safety Testing
Baillie, T. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9440 · Cited by 371
Yin, H., Killeen, K., Brennen, R., Sobek, D., Werlich, M., & van de Goor, T. (2005) · Analytical Chemistry · doi:10.1021/ac049068d · Cited by 362
Liquid chromatography/atmospheric pressure ionization–mass spectrometry in drug metabolism studies
Kostiainen, R., Kotiaho, T., Kuuranne, T., & Auriola, S. (2003) · Journal of Mass Spectrometry · doi:10.1002/jms.481 · Cited by 349
Gas chromatography‐mass spectrometry methods for structural analysis of fatty acids
Christie, W. W. (1998) · Lipids · doi:10.1007/s11745-998-0214-x · Cited by 347
LC/MS applications in drug development
Lee, M. S., & Kerns, E. H. (1999) · Mass Spectrometry Reviews · doi:10.1002/(sici)1098-2787(1999)18:3/4<187::aid-mas2>3.0.co;2-k · Cited by 339
Radiocarbon Dating Using Electrostatic Accelerators: Negative Ions Provide the Key
Bennett, C. L., Beukens, R. P., Clover, M. R., Gove, H. E., Liebert, R. B., Litherland, A. E., Purser, K. H., & Sondheim, W. E. (1977) · Science · doi:10.1126/science.198.4316.508 · Cited by 330
THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
Roffey, S. J., Cole, S., Comby, P., Gibson, D., Jezequel, S. G., Nedderman, A. N. R., Smith, D. A., Walker, D. K., & Wood, N. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.6.731 · Cited by 330
Self-citationElectrospray-ion spray: a comparison of mechanisms and performance
Ikonomou, M. G., Blades, A. T., & Kebarle, P. (1991) · Analytical Chemistry · doi:10.1021/ac00018a017 · Cited by 322
Drugs and the Pharmaceutical Sciences
Neubert, R. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00002-4 · Cited by 311
Returns on Research and Development for 1990s New Drug Introductions
Grabowski, H., Vernon, J., & DiMasi, J. A. (2002) · PharmacoEconomics · doi:10.2165/00019053-200220003-00002 · Cited by 311
High-Throughput Screening in Drug Metabolism and Pharmacokinetic Support of Drug Discovery
White, R. E. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.133 · Cited by 304
Guan, X., Hoffman, B., Dwivedi, C., & Matthees, D. P. (2003) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(02)00594-0 · Cited by 303
Hopfgartner, G., Varesio, E., Tschäppät, V., Grivet, C., Bourgogne, E., & Leuthold, L. A. (2004) · Journal of Mass Spectrometry · doi:10.1002/jms.659 · Cited by 287
Metabolomics applications of FT‐ICR mass spectrometry
Brown, S. C., Kruppa, G., & Dasseux, J. (2005) · Mass Spectrometry Reviews · doi:10.1002/mas.20011 · Cited by 286
Fluorotelomer Alcohol BiodegradationDirect Evidence that Perfluorinated Carbon Chains Breakdown
Wang, N., Szostek, B., Buck, R. C., Folsom, P. W., Sulecki, L. M., Capka, V., Berti, W. R., & Gannon, J. T. (2005) · Environmental Science & Technology · doi:10.1021/es0506760 · Cited by 260
Covey, T. R., Lee, E. D., & Henion, J. D. (1986) · Analytical Chemistry · doi:10.1021/ac00125a022 · Cited by 250
Rapid Production of Graphite Without Contamination for Biomedical AMS
Vogel, J. S. (1992) · Radiocarbon · doi:10.1017/s0033822200063529 · Cited by 240
High-temperature liquid chromatography
Greibrokk, T., & Andersen, T. (2003) · Journal of Chromatography A · doi:10.1016/s0021-9673(02)01963-5 · Cited by 231
Disposition and biotransformation of the antipsychotic agent olanzapine in humans.
Kassahun, K., Mattiuz, E. L., Nyhart, E. H., Obermeyer, B. D., Gillespie, T. A., Murphy, A., Rm, G., Tupper, D., Callaghan, J. T., & Lemberger, L. (1997) · PubMed · Cited by 211
LC/MS applications in drug development.
Lee, M. S., & Kerns, E. H. (1999) · PubMed · Cited by 207
Corcoran, O., & Spraul, M. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02749-1 · Cited by 206
Nassar, A.-E. F., Kamel, A. M., & Clarimont, C. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03280-5 · Cited by 204
Anari, M. R., Bakhtiar, R., Zhu, B., Huskey, S., Franklin, R. B., & Evans, D. C. (2002) · Analytical Chemistry · doi:10.1021/ac025712h · Cited by 196
Spraul, M., Freund, A. S., Nast, R. E., Withers, R. S., Maas, W. E., & Corcoran, O. (2003) · Analytical Chemistry · doi:10.1021/ac026203i · Cited by 192
van Beijsterveldt, L. E. C., Geerts, R. J. F., Leysen, J. E., Megens, A. A. H. P., Van den Eynde, H. M. J., Meuldermans, W. E. G., & Heykants, J. J. P. (1994) · Psychopharmacology · doi:10.1007/bf02245444 · Cited by 177
Wrona, M. D., Mauriala, T., Bateman, K. P., et al. (2005) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2101 · Cited by 177
Shockcor, J. P., Unger, S. E., Wilson, I. D., Foxall, P. J. D., Nicholson, J. K., & Lindon, J. C. (1996) · Analytical Chemistry · doi:10.1021/ac9606463 · Cited by 172
Xie, J., Miao, Y., Shih, J., Tai, Y.-C., & Lee, T. D. (2005) · Analytical Chemistry · doi:10.1021/ac0510888 · Cited by 162
Product ion scanning using a Q‐q‐Q linear ion trap (Q TRAP TM ) mass spectrometer
Hager, J. W., & Yves Le Blanc, J. C. (2003) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1020 · Cited by 161
Preuss, R., Koch, H. M., & Angerer, J. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.11.048 · Cited by 155
Peer Reviewed: Systematic LC/MS Metabolite Identification in Drug Discovery
Clarke, N. J., Rindgen, D., Korfmacher, W. A., & Cox, K. (2001) · Analytical Chemistry · doi:10.1021/ac012480y · Cited by 155
Ilett, K. F., Ethell, B. T., Maggs, J. L., Davis, T. M. E., Batty, K. T., Burchell, B., Bình, T. Q., Thư, L. T. A., Hung, N. C., Pirmohamed, M., et al. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.9.1005 · Cited by 155
Fura, A., Shu, Y., Zhu, M., Hanson, R. L., Roongta, V. A., & Humphreys, W. G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040066v · Cited by 151
SEEING THROUGH THE MIST: ABUNDANCE VERSUS PERCENTAGE. COMMENTARY ON METABOLITES IN SAFETY TESTING
Smith, D. A., & Obach, R. S. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005041 · Cited by 138
Quantification and Rapid Metabolite Identification in Drug Discovery Using API Time-of-Flight LC/MS
Zhang, N. R., Fountain, S. T., Bi, H., & Rossi, D. T. (2000) · Analytical Chemistry · doi:10.1021/ac9911701 · Cited by 136
Hopfgartner, G., Husser, C., & Zell, M. (2003) · Journal of Mass Spectrometry · doi:10.1002/jms.420 · Cited by 129
Soglia, J. R., Harriman, S. P., Zhao, S. X., Barberia, J. T., Cole, M. J., Boyd, J. G., & Contillo, L. G. (2004) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2004.04.019 · Cited by 110
Investigating the human metabolism of acetaminophen using UPLC and exact mass oa-TOF MS
Johnson, K. A., & Plumb, R. S. (2005) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2005.04.048 · Cited by 104
Kuuranne, T., Kotiaho, T., Pedersen‐Bjergaard, S., et al. (2003) · Journal of Mass Spectrometry · doi:10.1002/jms.393 · Cited by 92
Axelsson, B., Jörnten‐Karlsson, M., Michelsen, P., & Abou-Shakra, F. R. (2001) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.238 · Cited by 91
Nassar, A.-E. F., Kamel, A. M., & Clarimont, C. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03297-0 · Cited by 86
Thevis, M., Makarov, A., Horning, S. R., et al. (2005) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2204 · Cited by 75
HPLC assay for bupropion and its major metabolites in human plasma
Loboz, K. K., Gross, A. S., Ray, J. E., & McLachlan, A. J. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.06.009 · Cited by 75
Calcium-41 as a long-term biological tracer for bone resorption
Elmore, D., Bhattacharyya, M. H., Sacco-Gibson, N., & Peterson, D. P. (1990) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/0168-583x(90)90471-6 · Cited by 72
Li, A. C., Alton, D., Bryant, M., & Shou, W. Z. (2005) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2008 · Cited by 66
(2004) · PubMed · Cited by 66
Leavens, W. J., Lane, S. J., Carr, R. M., Lockie, A. M., & Waterhouse, I. (2002) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.559 · Cited by 65
Metabolite Identification in Drug Discovery
Swarbrick, J. (2006) · CRC Press eBooks · doi:10.1201/b21612-18 · Cited by 63
Evaluation of a C18 hybrid stationary phase using high-temperature chromatography
Liu, Y., Grinberg, N., Thompson, K. C., Wenslow, R. M., Neue, U. D., Morrison, D., Walter, T. H., O’Gara, J. E., & Wyndham, K. D. (2005) · Analytica Chimica Acta · doi:10.1016/j.aca.2005.08.026 · Cited by 56
Rüfer, C. E., Glatt, H. R., & Kulling, S. E. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.004929 · Cited by 55
Li, Y., Li, A. C., Shi, H., Zhou, S., Shou, W. Z., Jiang, X., Weng, N., & Lauterbach, J. H. (2005) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2196 · Cited by 50
Bridging cheminformatic metabolite prediction and tandem mass spectrometry
Anari, M. R., & Baillie, T. A. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03445-8 · Cited by 49
Nassar, A. E. F. (2003) · Journal of Chromatographic Science · doi:10.1093/chromsci/41.8.398 · Cited by 48
Mauriala, T., Chauret, N., Oballa, R. M., et al. (2005) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2013 · Cited by 47
Scarfe, G. B. (1999) · Xenobiotica · doi:10.1080/004982599238821 · Cited by 47
Barry, S. J., Carr, R. M., Lane, S. J., et al. (2003) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.957 · Cited by 47
A new accelerator mass spectrometry system for -quantification of biochemical samples
Ognibene, T. J., Bench, G., Brown, T. A., Peaslee, G. F., & Vogel, J. S. (2002) · International Journal of Mass Spectrometry · doi:10.1016/s1387-3806(02)00734-0 · Cited by 43
Brenninkmeijer, C. A. M., & Röckmann, T. (1998) · Rapid Communications in Mass Spectrometry · doi:10.1002/(sici)1097-0231(19980430)12:8<419::aid-rcm176>3.0.co;2-s · Cited by 43
The Influence of DMPK as an Integrated Partner in Modern Drug Discovery
Riley, R. J., Martin, I. J., & Cooper, A. E. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337135 · Cited by 42
Marshall, A. G. (1996) · Accounts of Chemical Research · doi:10.1021/ar9501481 · Cited by 37
Deng, Y., Wu, J., Zhang, H., & Olah, T. V. (2004) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1540 · Cited by 30
Xu, X., Ziegler, R. G., Waterhouse, D. J., Saavedra, J. E., & Keefer, L. K. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00539-1 · Cited by 28
Kamel, A. M., & Munson, B. (2007) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2007.05.001 · Cited by 28
Do Drug Metabolism and Pharmacokinetic Departments Make Any Contribution to Drug Discovery?
Smith, D. A., Schmid, E. F., & Jones, B. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241130-00001 · Cited by 23
Tandon, R. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00146.x · Cited by 21
Chemically Reactive Metabolites in Drug Discovery and Development
Baillie, T. A. (2003) · Informa Healthcare eBooks · doi:10.1201/9781420028485.ch4 · Cited by 12
Johnson, K. A., & Prakash, C. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.004713 · Cited by 6
Self-citation
Cited by
Analytical and statistical approaches to metabolomics research
Issaq, H. J., Van, Q. N., Waybright, T. J., Muschik, G. M., & Veenstra, T. D. (2009) · Journal of Separation Science · doi:10.1002/jssc.200900152 · Cited by 227
Guo, B., Chen, B., Liu, A., Zhu, W., & Yao, S. (2012) · Current Drug Metabolism · doi:10.2174/138920012803341401 · Cited by 80
Metadata
- Authors
- Prakash, C., Shaffer, C. L., & Nedderman, A.
- Venue
- Mass Spectrometry Reviews
- Publisher
- Wiley
- Published
- 2007-04-02
- Volume
- 26
- Issue
- 3
- Pages
- 340-369
- ISSN
- 0277-7037 (ISSN-L)
- 1098-2787
- OpenAlex
- W2004170415
- Cited by
- 302
- References
- 85
- FWCI
- 13.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.